The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trial

Saved in:
Bibliographic Details
Published in:Neuroscience Applied 2022, Vol.1, p.100511, Article 100511
Main Authors: Goodwin, G.M., Aaronson, S.T., Dunlop, B.W., Feifel, D., Hellerstein, D.J., Hewitt, N., Marwood, L., Mistry, S., Somers, M., Stansfield, S.C., Tsai, J., Williams, S., Young, A.H., Zisook, S., Malievskaia, E.
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2772-4085
2772-4085
DOI:10.1016/j.nsa.2022.100511